BIOBASE Biological Databases to Coordinate EU-backed Project to Develop Technology for Studying Mechanisms of Disease

WOLFENBUTTEL, Germany & BEVERLY, Mass.--(BUSINESS WIRE)--BIOBASE, a leading provider of knowledge solutions for the life sciences industry, announced today that they have received a European Union research contract to develop innovative technology to analyze complex disease mechanisms. The three-year, 3 million Euro project, called Net2Drug, will be coordinated by BIOBASE and developed as a collaboration with several international participants. The project's goal is to create a sophisticated “toolbox” integrating cutting edge bioinformatics, chemoinformatics, and experimental methods to identify potential therapeutic targets.